Formerly vice president and head of the health practice in the Washington D.C. office of a multinational communications firm, Stephen Bingham has 14 years of experience in design and execution of effective health science communications. He has created and managed programs to launch new pharmaceutical and medical device products and conducted media relations, marketing and issue management programs. He also facilitated communication advocacy partnerships in public and private sector and designed and implemented launch communications programs for pharmaceutical products such as Pharmacia’s antibiotic Zyvox®, GlaxoSmithKline’s Valtrex® for genital herpes and Abbott Laboratories’ protease inhibitor Norvir® to treat HIV/AIDS.